IL12 as an adjuvant for vaccines designed to prevent infection and immunopathology by schistosomes.
Wynn
T A
TA
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Sher
A
A
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D016233:Immunotherapy, Active; D018664:Interleukin-12 / Q000627:therapeutic use*; D012555:Schistosomiasis mansoni / Q000473:pathology* / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D018664:Interleukin-12